Persistent inequities in the Deep South highlight the urgent need to reimagine how research and clinical systems are designed ...
Multi-year content partnership agreements will enable clinicians using Abridge to leverage peer-reviewed research before, during, and after patient conversations within existing workflows and ...
Real-world study at CUF, Portugal's largest private healthcare network: Ada's accurate, medical-grade assessment changed the behavior of 3 in 5 patients -- and more than doubled the proportion ...
AI's performance in diagnostic tasks exceeds that of physicians, indicating a shift towards integrating advanced models in ...
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that the results from the Phase 3 ...
Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...
Abridge, the leading enterprise-grade AI platform for clinical conversations, today announced content partnerships with NEJM Group, publisher of the New England Journal of Medicine, and the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results